Stay updated on Soticlestat in Rare Epilepsies Clinical Trial

Sign up to get notified when there's something new on the Soticlestat in Rare Epilepsies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Soticlestat in Rare Epilepsies Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study status on the page has been updated to Terminated, with an explanation that termination stemmed from external negative results and not patient safety. This marks the closure of the trial on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-06-01T02:49:32.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page revision was updated to v3.5.4, replacing the previous v3.5.3. This reflects a minor update to the page’s metadata and formatting.
    Difference
    0.1%
    Check dated 2026-05-17T11:19:41.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a minor site release without changing the clinical trial information presented.
    Difference
    0.0%
    Check dated 2026-04-25T18:39:33.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:26:52.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The ENDYMION 1 study (NCT03635073) was terminated due to negative results from related phase 3 studies, and supplementary data were deemed unnecessary. The record now reflects the termination and includes posted results and QC date updates in 2026.
    Difference
    0.1%
    Check dated 2026-04-04T06:09:20.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Added 'Severe myoclonic epilepsy in infancy' to the Conditions section and removed 'Dravet syndrome'.
    Difference
    0.0%
    Check dated 2026-03-28T02:59:32.000Z thumbnail image

Stay in the know with updates to Soticlestat in Rare Epilepsies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Soticlestat in Rare Epilepsies Clinical Trial page.